Ramkhamhaeng Hospital PCL (BKK:RAM)
Thailand · Delayed Price · Currency is THB 18.10
+0.20 (1.12%)
At close: Jan 30, 2026
Ramkhamhaeng Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 11,883 | 9,868 | 9,634 | 10,687 | 12,664 | 7,826 | |
Revenue Growth (YoY) | 21.30% | 2.42% | -9.85% | -15.62% | 61.83% | 75.95% |
Cost of Revenue | 9,040 | 7,532 | 7,461 | 7,810 | 7,941 | 6,785 |
Gross Profit | 2,843 | 2,336 | 2,174 | 2,876 | 4,723 | 1,041 |
Selling, General & Admin | 1,785 | 1,360 | 1,520 | 1,513 | 1,364 | 1,242 |
Operating Expenses | 1,867 | 1,441 | 1,559 | 1,513 | 1,364 | 1,242 |
Operating Income | 975.78 | 894.63 | 614.3 | 1,363 | 3,359 | -201.07 |
Interest Expense | -434.37 | -428.72 | -332.3 | -243.38 | -239.31 | -211 |
Interest & Investment Income | 262.6 | 267.99 | 296.43 | 355.19 | 316.5 | 259.33 |
Earnings From Equity Investments | 8.95 | 56.81 | 707.72 | 1,002 | 2,259 | 119.67 |
Other Non Operating Income (Expenses) | 117.55 | 108.83 | 92.65 | 102.12 | 79.51 | 107.43 |
EBT Excluding Unusual Items | 930.5 | 899.53 | 1,379 | 2,579 | 5,775 | 74.35 |
Gain (Loss) on Sale of Investments | 189.5 | - | 313.89 | 84.12 | 122.15 | 862.63 |
Gain (Loss) on Sale of Assets | -15.55 | -15.55 | 1.13 | 0.48 | - | - |
Pretax Income | 1,104 | 883.98 | 1,694 | 2,664 | 5,897 | 936.98 |
Income Tax Expense | 381.91 | 191.23 | 271.03 | 275.04 | 506.33 | 39.44 |
Earnings From Continuing Operations | 722.55 | 692.75 | 1,423 | 2,389 | 5,391 | 897.55 |
Minority Interest in Earnings | -72.41 | 35.08 | 128.43 | -214.83 | -1,220 | 373.54 |
Net Income | 650.14 | 727.83 | 1,551 | 2,174 | 4,171 | 1,271 |
Net Income to Common | 650.14 | 727.83 | 1,551 | 2,174 | 4,171 | 1,271 |
Net Income Growth | -49.68% | -53.08% | -28.64% | -47.89% | 228.15% | -11.46% |
Shares Outstanding (Basic) | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 |
Shares Outstanding (Diluted) | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 |
EPS (Basic) | 0.54 | 0.61 | 1.29 | 1.81 | 3.48 | 1.06 |
EPS (Diluted) | 0.54 | 0.61 | 1.29 | 1.81 | 3.48 | 1.06 |
EPS Growth | -49.68% | -53.08% | -28.64% | -47.89% | 228.15% | -11.46% |
Free Cash Flow | 655.59 | -35.6 | -259.77 | 631.6 | 2,413 | -20.18 |
Free Cash Flow Per Share | 0.55 | -0.03 | -0.22 | 0.53 | 2.01 | -0.02 |
Dividend Per Share | - | 0.400 | 0.900 | 1.100 | 0.760 | 0.720 |
Dividend Growth | - | -55.56% | -18.18% | 44.74% | 5.56% | - |
Gross Margin | 23.92% | 23.67% | 22.56% | 26.91% | 37.30% | 13.30% |
Operating Margin | 8.21% | 9.07% | 6.38% | 12.76% | 26.52% | -2.57% |
Profit Margin | 5.47% | 7.38% | 16.10% | 20.34% | 32.94% | 16.24% |
Free Cash Flow Margin | 5.52% | -0.36% | -2.70% | 5.91% | 19.05% | -0.26% |
EBITDA | 2,047 | 1,896 | 1,586 | 2,315 | 4,144 | 1,032 |
EBITDA Margin | 17.22% | 19.21% | 16.46% | 21.66% | 32.72% | 13.19% |
D&A For EBITDA | 1,071 | 1,001 | 971.54 | 951.2 | 784.55 | 1,233 |
EBIT | 975.78 | 894.63 | 614.3 | 1,363 | 3,359 | -201.07 |
EBIT Margin | 8.21% | 9.07% | 6.38% | 12.76% | 26.52% | -2.57% |
Effective Tax Rate | 34.58% | 21.63% | 16.00% | 10.33% | 8.59% | 4.21% |
Revenue as Reported | 12,437 | 10,229 | 10,334 | 11,219 | 13,218 | 9,025 |
Advertising Expenses | - | 53.38 | 48.18 | 66.26 | 67.88 | 57.86 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.